This page screens the US healthcare sector for stocks with a P/E between 1 and 18 and ROE of at least 8%, refreshed automatically from live data.
DeltaScreener builds this page from the US-listed stocks it tracks, using the following rules. A stock appears here only because it matches these rules; the page title names the criteria and is not a rating of any stock.
Top sectors in the current result set: Healthcare (33).
Click any ticker to open the full stock detail page with financials, valuation ratios, and more.
| # | Ticker | Company | Exchange | Price | Market Cap | P/E | P/B | ROE | ROA | Net Margin | D/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORMP | Oramed Pharmaceuticals Inc. | NASDAQ | $4.07 | $169.3M | 1.06 | 0.58 | 72.96% | 47.31% | — | 0.01 |
| 2 | RIGL | Rigel Pharmaceuticals, Inc. | NMS | $45.97 | $858.7M | 2.67 | 2.05 | 96.49% | 61.78% | 116.30% | 0.09 |
| 3 | QTTB | Q32 Bio Inc. | NASDAQ | $7.52 | $223.9M | 2.95 | 1.1 | 76.88% | 29.16% | 62.87% | 0.05 |
| 4 | CRMD | CorMedix Inc. | NASDAQ | $7.26 | $565.9M | 3.01 | 1.24 | 44.64% | 20.70% | 40.49% | 0.31 |
| 5 | INVA | Innoviva, Inc. | NASDAQ | $20.78 | $1.50B | 4.21 | 1.22 | 30.03% | 20.98% | 80.56% | 0.22 |
| 6 | CGEN | Compugen Ltd. | NASDAQ | $1.96 | $185.7M | 6.15 | 2.46 | 42.57% | 25.43% | 47.55% | 0.03 |
| 7 | AUPH | Aurinia Pharmaceuticals Inc | NASDAQ | $16.51 | $2.20B | 6.71 | 3.35 | 59.00% | 39.65% | 100.84% | 0.1 |
| 8 | GMRS | GMR Solutions Inc. | NYSE | $10.00 | $540.2M | 6.9 | 0.68 | 15.58% | 1.05% | 2.65% | 6.02 |
| 9 | UHS | Universal Health Services, Inc. | NYSE | $185.10 | $10.91B | 7.13 | 1.39 | 20.66% | 9.58% | 8.42% | 0.7 |
| 10 | NUTX | Nutex Health Inc. | NASDAQ | $186.10 | $1.27B | 8.21 | 3.75 | 51.88% | 18.65% | 21.25% | 0.88 |
| 11 | SPRO | Spero Therapeutics, Inc. | NMS | $1.10 | $64.1M | 8.5 | 1.56 | 16.17% | 13.99% | 17.18% | 0.05 |
| 12 | ACAD | ACADIA Pharmaceuticals Inc. | — | $19.12 | $3.29B | 8.87 | 2.62 | 32.39% | 21.83% | 33.42% | 0.06 |
| 13 | AVAH | Aveanna Healthcare Holdings Inc. | NASDAQ | $12.34 | $2.69B | 9.32 | 9.38 | 150.20% | 13.04% | 10.56% | 5.24 |
| 14 | NVO | Novo Nordisk A/S | NYSE | $38.83 | $171.36B | 9.65 | 5.06 | 59.09% | 19.57% | 35.35% | 0.63 |
| 15 | THC | Tenet Healthcare Corporation | NYSE | $267.25 | $21.52B | 9.93 | 4.65 | 50.63% | 7.31% | 10.27% | 2.84 |
| 16 | ZVRA | Zevra Therapeutics, Inc. | NASDAQ | $9.94 | $590.3M | 10.4 | 2.72 | 32.77% | 19.25% | 42.82% | 0.01 |
| 17 | SOLV | Solventum Corporation | NYSE | $85.81 | $14.61B | 10.69 | 3.18 | 28.96% | 10.07% | 17.26% | 1.1 |
| 18 | CI | The Cigna Group | NYSE | $302.30 | $79.88B | 11.22 | 1.68 | 15.24% | 4.08% | 2.27% | 0.75 |
| 19 | INMD | InMode Ltd. | NASDAQ | $14.16 | $814.8M | 11.27 | 1.32 | 11.80% | 10.76% | 20.69% | 0.01 |
| 20 | ZTS | Zoetis Inc. | NYSE | $79.32 | $32.78B | 11.69 | 9.43 | 69.25% | 17.35% | 27.49% | 2.93 |
| 21 | HCSG | Healthcare Services Group, Inc. | NASDAQ | $21.13 | $1.45B | 12.19 | 2.82 | 24.12% | 14.98% | 6.59% | 0.03 |
| 22 | MD | Pediatrix Medical Group, Inc. | NYSE | $27.38 | $2.22B | 12.31 | 2.34 | 19.89% | 8.21% | 8.96% | 0.7 |
| 23 | PBH | Prestige Consumer Healthcare Inc. | NYSE | $49.92 | $2.36B | 12.61 | 1.12 | 9.22% | 3.77% | 15.57% | 1.08 |
| 24 | HRMY | Harmony Biosciences Holdings, Inc. | NASDAQ | $37.95 | $2.21B | 12.66 | 2.3 | 20.06% | 13.20% | 18.88% | 0.15 |
| 25 | BMY | Bristol-Myers Squibb Company | NYSE | $59.75 | $122.05B | 13.85 | 5.75 | 46.75% | 10.59% | 18.87% | 1.93 |